virusPHIX™ virus inactivation medium launched by RNAssist & Rapid Labs Ltd.

RNAssist (Cambridge UK) and Rapid Labs Ltd (Colchester, UK) have launched the virusPHIX™ range of virus inactivating and RNA stabilising transport media, following successful SARS-CoV-2 inactivation testing carried out by Public Health England (PHE).

virusPHIX™ is a novel RNA stabiliser and virus inactivation medium based on technology developed by RNAssist Limited (Cambridge, UK). It has been shown to stabilise viral RNA for up to 1 year at 20°C, and has successfully inactivated all tested viruses and bacteria to date including SARS-CoV-2, Hepatitis B, Vaccinia, FIV, BVDV, Dengue, Zika, Influenza A and M. tuberculosis.

Unlike other virus transport mediums, virusPHIX™ does not contain guanidine, a highly toxic substance than can produce hydrogen cyanide when mixed with household cleaning products such as bleach. virusPHIX™ is a completely non-toxic, non-volatile reagent that can be used safely in a home testing environment and shipped for PCR analysis. The virusPHIX™ range of products are manufactured and sold worldwide by Rapid Labs Limited (Colchester, UK). With over 200 evaluators around the world, virusPHIX™ is a popular choice for RNA stabilisation thanks to its compatibility with most front-end RNA purification kits.

Public Health England and The Roslin Institute have demonstrated inactivation of SARS-CoV-2 within 10 minutes at 20°C. Qnostics UK have also demonstrated SARS-CoV-2 RNA stabilisation for 33 days at room temperature, and 12-month stability of 2 HCV strains at 20°C.

The virusPHIX™ range features 3 reagents suited to different applications:

  • virusPHIX+™ for swab and saliva testing
  • virusPHIX-LV (lower viscosity) for swab testing on automated liquid handling platforms (Ortho, Hamilton and Tecan)
  • virusPHIX-P9 for swab and saliva testing, especially when it is necessary to add sample directly into an RT-LAMP, LamPORE or RT-PCR assay without RNA purification.*

*virusPHIX-P9™ has been demonstrated to be directly compatible with LAMP assays. Please contact [email protected] to find out more.

Public Health England SARS-CoV-2 Inactivation Studies

PHE evaluated the reduction in virus titre SARS-CoV-2 spiked samples (tissue culture fluid) and presence of SARS-CoV-2 over a series of cell passages:

Treatment

Test 1: Reduction in SARS-CoV-2 Virus Titre

Test 2: Cell Passage

virusPHIX+™, 10 minutes

≥6.4 log10

Virus not detected

virusPHIX+™, 30 minutes

≥7.1 log10

Virus not detected

PBS Control, 10 minutes

None

Virus detected

PBS Control, 30 minutes

None

Virus detected

virusPHIX-LV™, 10 minutes

≥5.1 log10

Not tested

virusPHIX-LV™, 30 minutes

≥6.0 log10

Not tested

PBS Control

None

Not tested

virusPHIX-P9™, 10 minutes

≥4.4 log10

Not tested

virusPHIX-P9™, 30 minutes

≥4.8 log10

Not tested

PBS Control

None

Not tested

The full PHE Reports can be found online at https://assets.publishing.service.gov.uk.

More information about the virusPHIX™ range can be found in their online brochure: https://www.rapidlabs.co.uk/wp-content/uploads/virusPHIX-range-brochure-V4.pdf.

For ordering enquiries please contact [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rapid Labs Ltd. (2021, February 04). virusPHIX™ virus inactivation medium launched by RNAssist & Rapid Labs Ltd.. News-Medical. Retrieved on October 05, 2024 from https://www.news-medical.net/news/20210204/virusPHIXe284a2-virus-inactivation-medium-launched-by-RNAssist-Rapid-Labs-Ltd.aspx.

  • MLA

    Rapid Labs Ltd. "virusPHIX™ virus inactivation medium launched by RNAssist & Rapid Labs Ltd.". News-Medical. 05 October 2024. <https://www.news-medical.net/news/20210204/virusPHIXe284a2-virus-inactivation-medium-launched-by-RNAssist-Rapid-Labs-Ltd.aspx>.

  • Chicago

    Rapid Labs Ltd. "virusPHIX™ virus inactivation medium launched by RNAssist & Rapid Labs Ltd.". News-Medical. https://www.news-medical.net/news/20210204/virusPHIXe284a2-virus-inactivation-medium-launched-by-RNAssist-Rapid-Labs-Ltd.aspx. (accessed October 05, 2024).

  • Harvard

    Rapid Labs Ltd. 2021. virusPHIX™ virus inactivation medium launched by RNAssist & Rapid Labs Ltd.. News-Medical, viewed 05 October 2024, https://www.news-medical.net/news/20210204/virusPHIXe284a2-virus-inactivation-medium-launched-by-RNAssist-Rapid-Labs-Ltd.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.